Starting in the third quarter of 2020, the consumption rates of ciprofloxacin showed a positive trend, with total consumption increasing by 1.200 DID, outpatient consumption increasing by 1.102 DID, and hospital consumption increasing by 0.105 DID (all p values < 0.001).
At the outpatient level, consumption exhibited an immediate and marginally significant increase following 2020 ( p = 0.05244), interrupting an otherwise consistent downward trend.
In contrast, in the inpatient sector, a modest decrease was observed after 2020, although the overall upward trend over time did not reach statistical significance.